None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of both sexes between the age group of 10 18 years will be considered. Only patients diagnosed with acne vulgaris will be included in the study Scale for assessment is Acne-QoL Acne-specific quality of life questionnaire Patients and their parents or guardians must provide informed consent to participate in the study Patients with regular follow-up visits for the duration of the study
Exclusion criteria
Exclusion criteria: Patients with acne fulminans, acne rosacea, or other severe dermatological conditions Patients with significant systemic or endocrine disorders, such as polycystic ovary syndrome (PCOS) or active infections that could influence the study outcome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be to assess the clinical efficacy of individualized homoeopathic medicines in the management of acne vulgaris among the pediatric age group (10 18 years). This will be evaluated by comparing the pre-treatment and post-treatment clinical presentation of acne lesions, including reduction in number, severity, and type of lesions such as comedones, papules, pustules, and nodules.Timepoint: Outcome measures will be assessed at predefined time intervals during the study period as follows: Baseline (Week 0) Prior to initiation of intervention Week 4 (1 Month) First follow-up assessment Week 8 (2 Months) Second follow-up assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome of the study will be to evaluate the improvement in the quality of life (QoL) of patients suffering from acne vulgaris. This will be assessed using a validated Acne-specific Quality of Life Questionnaire (Acne-QoL) by comparing scores before & after the intervention.Timepoint: Secondary Outcome Time Points of Assessment The secondary outcomes will be assessed at the following predefined time points: Baseline (Week 0) Prior to initiation of intervention Week 4 First follow-up assessment Week 8 Second follow-up assessment | — |
Countries
India
Contacts
Vidyanagar Road, Beed Maharashtra 431122 India